PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NCSRT

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration - NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, Florida
NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration

 

NewswireToday - /newswire/ - Apex, NC, United States, 2008/02/08 - NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, Florida.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

NCSRT is presenting “A comparison of product yield using either centrifugation and microfiltration or simultaneous membrane processing with SmartFlow™ TFF” at the Waterside Conference in Miami, FL. The data, generated by Viventia Biotech of Winnipeg, Manitoba, Canada, demonstrates monoclonal antibody F (ab) fragment yield improvements of 345% when compared to centrifugation, microfiltration, and diafiltration processes previously employed. The scientists at Viventia examined two different centrifuge technologies, stack disc and tubular bowl configurations. The SmartFlow filtration system was designed to operate in a concurrent process with the antibody fragment being harvested using a 0.2 um microfilter in the first loop and the target product being concentrated in a second loop with a 30 kDa ultrafilter. The permeate from the second loop was fed back into the first loop harvest tank to serve as the diafiltration buffer.

In addition to the significantly improved yield, the concurrent process system from NCSRT reduces downstream cycle time for the filtration, concentration, and diafiltration by 40%, saves thousands of liters of diafiltration buffer, reduces capital costs for tanks, and reduces filter element costs. The test result data predicted that the improved yield would reduce the number of fermentation runs required to produce 1 kg of product from 38 to 12. The benefit of the reduction in fermentation runs required to produce one kg of product provided additional cost savings and increased the annualized production capacity of the plant significantly.

Working collaboratively with NCSRT provided Viventia scientists a rapid, cost effective solution for dramatically improving the efficiency of their downstream processes.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NCSRT

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


NCSRT Presents SmartFlow™ TFF Performance Advantages Over Centrifugation and Microfiltration

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Vander Hoff - NCSRT.com 
919-387-8460 mvanderhoff[.]ncsrt.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NCSRT securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NCSRT / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)